














Antibacterial activity of bovine milk lactoferrin on the emerging foodborne 1 
pathogen Cronobacter sakazakii: effect of media and heat treatment 2 
S. Harounaa, J.J. Carramiñanab, F. Navarroa, M.D. Péreza, M. Calvoa, L. 3 
Sáncheza*  4 
aTecnología de los Alimentos, bNutrición y Bromatología, Facultad de 5 
Veterinaria, Universidad de Zaragoza, Miguel Servet, 177, 50013 Zaragoza, 6 
Spain  7 
* Corresponding author. Tel.: +34 976761585; fax: +34 976761612. 8 
E-mail address: lousanchez@unizar.es (L. Sánchez).  9 
 10 
ABSTRACT 11 
Cronobacter sakazakii is a pathogen transmitted by food, with high osmotic 12 
resistance and tolerance to desiccation, which affects mainly to newborns, 13 
infants and immunocompromised adults. C. sakazakii infection in infants has 14 
been associated with consumption of powdered milk. The purpose of this study 15 
was to evaluate the antibacterial activity of native and iron-saturated bovine 16 
lactoferrin (bLF) (from 0.5 to 5 mg/ml) on non-desiccated and desiccated C. 17 
sakazakii (104 CFU/ml) in different media (phosphate buffer, bovine skim milk 18 
and whey). In general, native bLF was the only effective form that inhibited 19 
growth of C. sakazakii in all media, its activity increasing with concentration and 20 
time of incubation. These results suggest that the antibacterial effect of bLF on 21 
C. sakazakii is mainly due to iron sequestration. However, iron-saturated bLF 22 
showed some effect by reducing the viability of C. sakazakii in whey. There has 23 
not been observed an increased sensitivity of desiccated bacteria to native bLF 24 
in phosphate buffer. However, although the antibacterial activity of native bLF 25 
against non-desiccated C. sakazakii was drastically reduced in milk or whey 26 
compared to phosphate buffer, there was a certain activity when it was assayed 27 
against desiccated cells in those media. The effect of some heat treatments on 28 
the antibacterial activity of native bLF was evaluated and only those of 72°C for 29 
15 s, 85°C for 15 s, and 63°C for 30 min maintained  its whole activity. 30 
 31 
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1. Introduction 34 
Cronobacter sakazakii is an emerging pathogen transmitted by food that has 35 
been associated with meningitis (Burdette & Santos, 2000), sepsis (Simmons, 36 
Gelfand, Haas, Metts, & Feruson, 1989), bacteremia (Noriega, Kotloft, Martin, & 37 
Schwalb, 1990) and necrotizing enterocolitis (Van Acker et al., 2001), mainly 38 
affecting to newborns, infants, and immunocompromised adults (Lai, 2001). 39 
Recently, Iversen et al. (2008) reclassified Enterobacter sakazakii as a new 40 
genus, Cronobacter, in which fives species were included: C. sakazakii, C. 41 
malonaticus, C. turicensis, C. muytjensii and C. dublinensis. Although the 42 
outbreaks caused by this pathogen are scarce, infections with C. sakazakii are 43 
often accompanied by a high rate of mortality that can reach 80% (Lehner & 44 
Stephan, 2004; Kim & Beuchat, 2005). C. sakazakii is a Gram-negative, motile, 45 
non-spore forming, ubiquitous, facultative anaerobic bacteria, belonging to the 46 
family Enterobacteriaceae. It can grow over a wide temperature range (6-47ºC) 47 
and is inactivated at 70°C. The consumption of cont aminated powdered infant 48 
formula (PIF) has been mainly associated with the majority of outbreaks caused 49 
by C. sakazakii (Burdette & Santos, 2000; Lai, 2001; Van Acker et al., 2001). 50 
The Codex Alimentarius Commission (CAC) of the United Nations provides 51 
regulations relevant to PIF, such as that Cronobacter spp. should be absent in 52 
30 samples of 10 g in finished PIF products (CAC, 2008). The European Union 53 
officially introduced similar microbiological standards (European Commission, 54 
2007). 55 
C. sakazakii is usually inactivated during pasteurization of PIF (Nazarowec-56 
White & Farber, 1997a). Therefore, the presence of this bacterium in milk can 57 
be caused by post-processing environmental contamination, addition of 58 
contaminated ingredients (Nazarowec-White & Farber, 1997b) or colonization 59 
by C. sakazakii of utensils used in milk preparation. It has been shown that C. 60 
sakazakii have a remarkable resistance in dry media for periods at least of two 61 
years (Caubilla-Barron & Forsythe, 2007). This feature represents a competitive 62 
advantage, facilitating their prevalence in products with low water content 63 
(Edelson-Mammel, Porteus, & Buchanam, 2005). Cronobacter spp. may 64 
accumulate solutes such as trehalose which protects the microorganism against 65 















Joosten, 2003). Heat treatment of water at ≥70°C for reconstitution of PIF has 67 
been recommended by FAO and WHO (2004). However, this treatment may 68 
adversely affect the sensory quality and nutritional value of this essential food 69 
for baby development. The heat treatment necessary to reduce the number of 70 
Cronobacter cells in milk and to avoid its proliferation could be decreased by 71 
combining it with antimicrobial compounds. According to WHO 72 
recommendations, great interest has recently grown in using natural 73 
antimicrobials, such as lactoferrin (LF), to avoid proliferation of C. sakazakii in 74 
infant formula. From a regulatory point of view, bovine lactoferrin (bLF) is 75 
considered safe under the proposed uses and levels in a variety of foods for 76 
nutritional applications (EFSA, 2012a,b), i.e., infant and follow-on formulas, 77 
dietary food, dairy products, yoghurts, and chewing gums (European 78 
Commission, 2012a,b). 79 
Lactoferrin is a glycoprotein of the transferrin family present in the majority of 80 
external secretions and mucosal surfaces, milk being its main source. 81 
Lactoferrin binds two atoms of iron and due to this capacity several functions 82 
have been attributed to it, such as antibacterial, antioxidant, antitumoral and 83 
immunomodulatory (Sánchez, Calvo, & Brock, 1992a). 84 
Almost all bacteria require iron for their growth; therefore LF devoid of iron is 85 
capable of preventing its utilization by some bacteria (Orsi, 2004). A large 86 
number of studies have demonstrated the bacteriostatic and bactericidal effect 87 
of LF, against a wide range of Gram-positive and Gram-negative bacteria 88 
(Farnaud & Evans, 2003). However, other mechanisms besides iron holding 89 
can be involved in the antibacterial activity of LF, such as blocking microbial 90 
metabolism of carbohydrates or destabilizing the bacterial cell wall (Sánchez, 91 
Calvo, & Brock, 1992a). 92 
The aim of this study was to evaluate the antibacterial activity of bLF on the 93 
emerging foodborne pathogen C. sakazakii and the influence of different 94 
factors. Thus, iron saturation and concentration of bLF, desiccation of bacterial 95 
cells, media, incubation time and heat treatment have been evaluated. The 96 
effect of heat treatment is especially important since denaturation of bioactive 97 
















2. Materials and methods 100 
2.1. Culture of C. sakazakii and preparation of desiccated cells 101 
A freeze-dried culture of C. sakazakii CECT 858, equivalent to strain ATCC 102 
29544, was supplied by the Spanish Type Culture Collection (CECT, Valencia, 103 
Spain). After reviving freeze-dried culture, it was stored at -70°C in sterile 104 
cryopreservation vials. Working cultures were obtained by transferring a porous 105 
bead of stock culture into 10 ml of Trypticase soy broth (TSB), incubating at 106 
37°C for 24 h and transferring a loop to Trypticase  soy agar (TSA). After 24 h at 107 
37°C, an isolated colony was transferred to 10 ml o f TSB and was incubated at 108 
37°C for 24 h. 109 
Desiccated cells of C. sakazakii were prepared as described by Al-Nabulsi et 110 
al. (2009), dispensing a volume of 1 ml of freshly prepared suspension from a 111 
single colony of C. sakazakii in 50 µl portions on a sterile Petri dish. The plate 112 
was placed at 40°C in an incubator to be air-dried.  After 2 h, the plate was 113 
placed in a desiccator at room temperature for 4 d, and afterwards, 2 ml of 0.2% 114 
(w/v) peptone water were added to the plate to collect desiccated cells, mixed 115 
with 8 ml of 0.2% peptone water and serial decimal dilutions in 1% peptone 116 
water were used to yield a suspension of 104 CFU/ml for antibacterial activity 117 
assays. 118 
2.2. Preparation of native bLF solutions 119 
Native bLF was kindly provided by Tatua Nutritionals Company (Morrinsville, 120 
New Zealand) and had an iron-saturation below 10%. The purity of bLF was 121 
checked by SDS-PAGE, which showed a single band corresponding to a 122 
protein of about 80 KDa and purity higher than 90%. The stock solution of bLF 123 
was prepared from the native protein in ultrapure water at 20 mg/ml and 124 
sterilized through a low-binding protein 0.22 µm filter. After filtration, the 125 
absorbance was measured at 280 nm and the concentration of bLF determined 126 
by considering a molar extinction coefficient (Ε1%) of 1.27 ml/cm/g. The final 127 
concentration of bLF solutions was adjusted to 1, 2, 5 and 10 mg/ml. 128 















Native bLF was saturated with iron by adding ferrinitrilotriacetate (FeNTA) 130 
solution as described previously (Ismail & Brock, 1993). Afterwards, bLF was 131 
subjected to Sephadex G-25 chromatography to remove unbound iron. The 132 
iron-saturated bLF solution was filtered through 0.22 µm and the concentration 133 
was determined, considering a Ε1% of 1.51 ml/cm/g. The concentration of 134 
solutions was adjusted to 1, 2, 5 and 10 mg/ml. 135 
2.4. Effect of heat treatment on bLF 136 
To study the effect of different heat treatments on the antibacterial activity of 137 
bLF against non-desiccated C. sakazakii, native or iron-saturated bLF were 138 
dissolved at a concentration of 5 mg/ml in phosphate buffer solution, composed 139 
by 15 mM monopotassium phosphate, 8 mM dibasic sodium phosphate, 14 mM 140 
NaCl and 2 mM KCl, pH 7.4 (PBS). A volume of 650 µl of bLF solutions was 141 
subjected to different heat treatments in sterile glass vials of 12.0 mm outer 142 
diameter and 11.6 mm inner diameter. Treatments were performed in a water 143 
bath with agitation and temperature controlled with an accuracy of ± 0.1°C. The 144 
vials were removed at several times and immediately immersed into an ice-145 
water bath. Heat treatments performed were: 63°C fo r 30 min, low-temperature 146 
long-time pasteurization (LTLT); 72°C for 15 s, hig h-temperature short-time 147 
pasteurization (HTST); 72°C for 15 min, that was ch osen as an intermediate 148 
treatment between HTST and high pasteurization; 85°C for 15 s and 85°C for 149 
10 min, treatments used normally in the manufacture of some dairy products. 150 
Samples of heat treated bLF were subjected to electrophoresis and radial 151 
immunodiffusion to evaluate the degree of protein denaturation. 152 
2.5. SDS-PAGE electrophoresis and radial immunodiffusion 153 
Heat treated bLF was analyzed by SDS-PAGE. A volume of 50 µl of the 154 
treated samples was added to 40 µl of 10 mM Tris 1 mM EDTA, pH 8, and 10 µl 155 
of 25% SDS and treated at 100°C for 5 min. Afterwar ds, 1 µl of each sample 156 
was applied to a 7.5 % polyacrylamide gel and electrophoresis developed in a 157 
Phast System equipment (Pharmacia Biotech, Uppsala Sweden). After the 158 















The immunochemical reactivity of heat-treated bLF was determined by radial 160 
immunodifusion, as described previously (Sánchez et al. 1992b), by using 0.4, 161 
0.2, 0.1 and 0.05 mg/ml bLF standards. After diffusion for 72 h, the gel was 162 
washed with saline buffer, stained with Coomassie blue type G, destained and 163 
diameters of radial precipitate measured. 164 
2.6. Antibacterial activity assay 165 
The media used to evaluate the antibacterial activity of native and iron-166 
saturated bLF were: commercial ultra-high temperature (UHT) bovine skim milk, 167 
bovine whey obtained from UHT milk by ultrafiltration with 100,000 MWCO 168 
hollow fiber, and PBS. Whey and PBS were filtered through 0.22 µm. 169 
Non-desiccated or desiccated C. sakazakii were diluted in 1% peptone water 170 
to achieve 104 CFU/ml. A volume of 100 µl of those suspensions was added to 171 
each well of a microtiter plate with 100 µl of UHT skim milk, whey or PBS 172 
containing native or iron-saturated bLF at a final concentration of 0.5, 1, 2.5 or 5 173 
mg/ml. The final concentration of bacteria in the well was approximately 104 174 
CFU/ml. Control samples consisted of media without bLF.  175 
Heat treated bLF was assayed at 2.5 mg/ml in PBS against non-desiccated 176 
bacteria (104 CFU/ml). In this assay, non-treated native bLF at 2.5 mg/ml was 177 
included as reference. 178 
The plates were incubated at 37°C for 4 and 8 h. Th e number of viable cells 179 
was determined by serially diluting the content of each well in 1% peptone water 180 
and plating on TSA plates which were incubated at 37°C for 24 h. Each well 181 
was seeded by duplicate. 182 
2.7. Statistical analysis 183 
Experiments were performed three times using freshly prepared samples. 184 
Mean and standard deviations were calculated from all the data obtained in the 185 
experiments performed. Data were statistically evaluated by t test and ANOVA 186 
according to Duncan test using the SPSS 19.0 package for Windows. 187 
3. Results 188 
3.1. Activity of native and iron-saturated bLF against non-desiccated and 189 















The results showed that native bLF in PBS exerted antibacterial activity 191 
against non-desiccated C. sakazakii, from 0.5 to 5 mg/ml, being significantly 192 
different from the control at concentrations above 1 mg/ml at 4 and 8 h (Fig. 193 
1A). This antibacterial activity increased with concentration and time of 194 
incubation, and after 8 h, the 5 mg/ml bLF solution reduced the bacterial counts 195 
7.98 log cycles, respect to the control. Iron-saturated bLF did not reduce 196 
significantly the growth of non-desiccated C. sakazakii at any concentration and 197 
incubation period (data not shown). 198 
The results obtained against desiccated C. sakazakii (Fig. 1B) showed a 199 
significant inhibitory effect of native bLF, except for the concentration of 0.5 200 
mg/ml, at 4 and 8 h. In general, the inhibitory effect of native bLF on desiccated 201 
cells appeared later respect to non-desiccated bacteria. The antibacterial effect 202 
of native bLF at 4 h was lower on desiccated bacteria than on non-desiccated 203 
bacteria for the same concentrations of protein. However, native bLF at 5 mg/ml 204 
produced practically the same reduction on the growth of desiccated C. 205 
sakazakii at 8 h, than on non-desiccated cells. The iron-saturated bLF did not 206 
show any antibacterial activity on desiccated bacteria (data not shown). 207 
3.2. Activity of native and iron-saturated bLF against non-desiccated and 208 
desiccated C. sakazakii in bovine skim milk and whey 209 
The antibacterial activity of native bLF against C. sakazakii was drastically 210 
reduced when the protein was assayed in bovine milk or whey, compared with 211 
PBS (Table 1). However, certain activity was observed for some concentrations 212 
of native bLF, being significant at 1, 2.5 and 5 mg/ml on desiccated C. sakazakii 213 
cells in whey after 4 h and at 5 mg/ml after 8 h, being the highest reduction of 214 
2.96 cycles. In milk the only significant activity was found for native bLF at 5 215 
mg/ml at 4 and 8 h on desiccated cells. The inhibitory activity of native bLF on 216 
non-desiccated cells was lower than one logarithmic cycle and only observed 217 
for 5 mg/ml. 218 
Furthermore, significant activity was found for iron-saturated bLF at 5 mg/ml 219 
on desiccated cells in whey at 4 and 8 h of incubation, with reductions of 1.49 220 















3.3. Effect of heat-treatment on the activity of native and iron-saturated LF 222 
against non-desiccated C. sakazakii in PBS 223 
Treatments of 72°C for 15 s, 85°C for 15 s and 63°C  for 30 min did not affect 224 
the antimicrobial activity of native bLF (Table 2). However, native bLF treated at 225 
72°C for 15 min and at 85°C for 10 min, showed lowe r antibacterial activity than 226 
that observed for bLF without treatment. Iron-saturated bLF did not show any 227 
antibacterial activity. 228 
Samples of heat treated bLF in PBS were subjected to SDS-PAGE to 229 
evaluate their aggregation (Fig. 2). Some LF aggregates were observed in the 230 
stacking gel, especially for samples treated at 72°C for 15 min, 85°C for 10 min 231 
and 85°C for 15 s. This can be due to the establish ment of interactions between 232 
bLF molecules under heating, consequently losing its antibacterial activity. 233 
The estimated concentrations of heat treated bLF determined by its 234 
immunoreactivity respect to the non-treated bLF are shown in Table 3. The 235 
treatments that affected bLF immunoreactivity in higher extent were 85°C for 10 236 
min and 72°C for 15 min, decreasing it to 4 and 10% , respectively. After 237 
treatment of bLF at 63°C for 30 min its immunoreact ivity decreased to 38%, 238 
although its antibacterial activity was still high as shown in Table 2. After 239 
treatment at 85°C for 15 s the immunoreactivity was  of 66% and at 72°C for 15 240 
s of 100% with respect to non-treated bLF. 241 
4. Discussion 242 
The antibacterial activity of LF has been largely demonstrated against a wide 243 
range of Gram-positive and Gram-negative bacteria (Jenssen & Hancock, 244 
2009). During the last years some bacteria have appeared as emerging 245 
pathogens, as is the case of C. sakazakii (Iversen et al., 2008), and therefore, 246 
there is little knowledge of LF activity against them. Natural antimicrobials have 247 
been proposed as food preservatives in the last years, by combining them with 248 
non-thermal treatments or lower treatments, in order to maintain the nutritional 249 
and organoleptic characteristics of food (Masschalck, Van Houdt, & Michiels, 250 
2001; Del Olmo, Calzada, & Nuñez, 2012). 251 
Although the most recognized mechanism for LF antibacterial activity is iron 252 















bacteria. This activity is related to its capacity to interact with the bacterial 254 
membrane, subsequently producing its destabilization, altering the bacterial 255 
metabolic processes and finally causing their death (Sánchez, Calvo & Brock, 256 
1992a). In the present work only native bLF has been proved as inhibitory for C. 257 
sakazakii, therefore being iron sequestration the most probable mechanism of 258 
that activity. However, a certain inhibitory effect of iron-saturated bLF was 259 
observed on desiccated C. sakazakii cells in bovine whey. This could be due to 260 
changes in the bacterial membrane produced by desiccation and/or to the 261 
contribution of some whey component to the inhibitory mechanism. 262 
C. sakazakii has been reported to be highly persistent in formulas with low 263 
water activity for long periods (Gurtler & Beuchat, 2007) and others indicated 264 
that capsulated strains of C. sakazakii were still recoverable from dry infant 265 
formula after two and a half years (Caubilla-Barron & Forsythe, 2007). Those 266 
studies carried out on desiccated bacteria intended to reproduce the conditions 267 
that might occur in PIF contaminated with C. sakazakii prior to transformation 268 
into powder. In an earlier study, Al-Nabulsi et al. (2009) reported that 269 
desiccation enhanced the sensitivity of Cronobacter spp. to the LF inhibitory 270 
activity, though they also found that nisin was less active on those desiccated 271 
cells. In contrast, the results obtained in this study did not show higher 272 
sensitivity of desiccated C. sakazakii to the effect of native bLF compared with 273 
non-desiccated cells. On the contrary, the desiccated cells reacted later to the 274 
activity of bLF and were inhibited at similar levels to the non-desiccated cells 275 
only at the highest concentration of bLF and after 8 h. This could be explained 276 
by different mechanisms reported for C. sakazakii to tolerate desiccation, such 277 
as synthesis of high levels of trehalose or glycine betaine (Breeuwer, Lardeau, 278 
Peter & Joosten, 2003), or production of exopolysaccharides (Jung, Choi, & 279 
Lee, 2013). 280 
The composition of media limits the activity of antimicrobials, specially when 281 
those are complex food matrices. This has been shown in studies carried out in 282 
meat (Venkitanarayanan, Zhao & Doyle, 1999; Del Olmo, Morales, & Nuñez, 283 
2009) or carrot juice (Chantaysakorn & Richter, 2000) in which the reduction of 284 
antibacterial activity of LF or its hydrolysates was attributed to the presence of 285 















2009; Del Olmo, Morales & Nuñez, 2009). In previous studies we evaluated the 287 
activity of native bLF (Conesa et al, 2010), human recombinant  lactoferrin from 288 
Aspergillus awamori (Conesa et al., 2008) and from rice (Conesa et al., 2009) 289 
on Listeria monocytogenes and Escherichia coli 0157: H7 in skim milk and 290 
whey. We found that skim milk and whey acted by protecting the bacteria 291 
reducing LF antibacterial activity. In the present work, we have also observed 292 
that bLF antibacterial activity against C. sakazakii is low when it was evaluated 293 
in bovine skimmed milk or whey. However, there was some activity of native 294 
and even iron-saturated bLF when were assayed on desiccated cells in milk or 295 
whey. Therefore, these results show that it is worthwhile investigating the 296 
procedures to improve LF antibacterial activity in milk and whey by modifying or 297 
eliminating some interfering components.  298 
Considering that bLF is being used as a bioactive ingredient in some 299 
processed foods, it is essential to study the effect of heat treatment on its 300 
antibacterial activity. In the present study we found that heat treatments of 72°C 301 
for 15 s, 85°C for 15 s and 63°C for 30 min  maintained the whole antibacterial 302 
activity of native bLF against C. sakazakii. Lactoferrin subjected to the highest 303 
treatments, 72°C for 15 min and 85°C for 10 min, diminished in a great extent 304 
its activity, though still having some effect. The results we previously obtained of 305 
the activity of heat treated bLF and human recombinant LF from rice and 306 
fungus, on three different bacteria: Escherichia coli O157:H7, Salmonella 307 
Enteritidis and Listeria monocytogenes were quite coincident with those 308 
obtained in the present work, as the only heat treatment that counteracted 309 
almost completely the antibacterial activity of LF was 85°C for 10 min (Conesa 310 
et al., 2008; Conesa et al., 2009; Conesa et al., 2010). Therefore, we can 311 
confirm that native bLF is very resistant to the most common pasteurization 312 
treatments, maintaining its antibacterial activity against C. sakazakii. 313 
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FIGURE AND TABLE CAPTIONS 1 
Figure 1. Effect of the concentration of native bLF on the growth of non-2 
desiccated (A) and desiccated (B) C. sakazakii in PBS after 4 and 8 h of 3 
incubation at 37°C. Each value represents the mean ± standard deviation of 4 
nine replicates from three independent experiments. *Significant differences for 5 
p<0.05 with respect to the control. 6 
Figure 2. SDS-PAGE of heat-treated native bLF. Lanes contain the following 7 
samples:1 and 7, non-treated bLF (5 mg/ml); 2, bLF treated at 63°C for 30 min; 8 
3, bLF treated at 72°C for 15 s; 4, bLF treated at 72°C for 15 min; 5, bLF treated 9 
at 85°C for 10 min; 6, bLF treated at 85°C for 15 s . Molecular weight markers: 10 
β-galactosidase (116 kDa), transferrin (76 kDa), glutamate deshidrogenase (53 11 
kDa). 12 
 13 
Table 1. Effect of the concentration of native bLF on the growth of non-14 
desiccated and desiccated C. sakazakii in bovine whey and skimmed milk after 15 
4 and 8 h of incubation at 37°C. Each value represe nts the mean ± standard 16 
deviation of nine replicates from three independent experiments. *Significant 17 
differences for p<0.05 with respect to the control. 18 
Table 2. Activity of heat-treated native and iron-saturated bLF (final 19 
concentration of 2.5 mg/ml) on the growth of non-dessicated C. sakazakii in 20 
PBS at 4 and 8 h of incubation at 37°C. Values repr esent the mean ± standard 21 
deviation of data from three independent experiments and three replicates at 22 
each experiment. Significant differences for *p<0.01 and **p<0.001 with respect 23 
to the control. an.d: not detected. 24 
Table 3. Effect of heat treatment on the concentration of native bLF determined 25 
by radial immunodifusion using polyclonal specific antibodies. Immunoreactivity 26 

















            
Bovine whey Non-desiccated C. sakazakii 
(log CFU/ml) 
Desiccated C. sakazakii 
(log CFU/ml) 
 4 hours 8 hours 4 hours 8 hours 
Control 5.91 ± 0.26 8.30 ± 0.06 6.05 ± 0.07 8.17 ± 0.31 
LF 0.5 mg/ml 5.87 ± 0.25 8.14 ± 0.09 6.01 ± 0.40 7.99 ± 0.40 
LF 1 mg/ml 5.75 ± 0.32 8.03 ± 0.07 6.01 ± 0.07 8.03 ± 0.32 
LF 2.5 mg/ml 5.71 ± 0.22 7.97 ± 0.09 5.91 ± 0.12 7.90 ± 0.37 
LF 5 mg/ml  5.55 ± 0.34* 7.70 ± 0.15 5.95 ± 0.10 7.91 ± 0.37 
Bovine milk Non-desiccated C. sakazakii 
(log CFU/ml) 
Desiccated C. sakazakii  
(log CFU/ml) 
 4 hours 8 hours 4 hours 8 hours 
Control  6.00 ± 0.09 8.20 ± 0.09 6.19 ± 0.05 8.32 ± 0.14 
LF 0.5 mg/ml 5.92 ± 0.09* 8.10 ± 0.06 5.32 ± 0.09 8.08 ± 0.07 
LF 1 mg/ml 5.78 ± 0.13* 8.00 ± 0.37 5.88 ± 0.11 7.81 ± 0.21 
LF 2.5 mg/ml 5.80 ± 0.09* 7.90 ± 0.32 5.74 ± 0.21 7.57 ± 0.43 







































 Native lactoferrin  
(log CFU/ml) 
Iron -saturated lactoferrin  
(log CFU/ml) 
 4 hours  8 hours  4 hours  8 hours  
Control  5.61 ± 0.31 7.75 ± 0.14 6.10 ± 0.11 8.61 ± 0.13 
Non-treated LF   nda nd 6.04 ± 0.13 8.47 ± 0.14 
LF 63°C 30 min  nd nd 5.94 ± 0.18 8.46 ± 0.09 
LF 72°C 15 s  nd nd 5.98 ± 0.19 8.44 ± 0.05 
LF 85°C 1 5 s nd nd 5.98 ± 0.17 8.44 ± 0.04 
LF 72°C 15 min  4.83 ± 1.49* 4.12 ± 3.48** 5.99 ± 0.14 8.12 ± 0.23 
LF 85°C 10 min  
 
4.32 ± 1.93* 
 
3.56 ± 3.57** 
 
5.99 ± 0.17 
 

















Heat treatment % Immunoreactivity 
Non-treated LF 100 
LF 63°C 30 min 38 
LF 72°C 15 s 100 
LF 85°C 15 s 66 
LF 72°C 15 min 10 





















































































































• Native bovine lactoferrin at 5 mg/ml reduces 8 log cycles C. sakazakii growth. 3 
• Milk and whey diminish lactoferrin antibacterial activity against C. sakazakii. 4 
• Pasteurization maintains lactoferrin antibacterial activity against C. sakazakii. 5 
 6 
 7 
 8 
 9 
